Skip to main content
. 2017 Nov 14;2017:5929234. doi: 10.1155/2017/5929234

Figure 9.

Figure 9

Blood clearance (a), pharmacokinetic profiles (b) of 99mTc- β-eudesmol in healthy mice and tissue distribution of β-eudesmol following intravenous (c), and oral (d) dosing of 99mTc- β-eudesmol in CCA-xenografted mice.